Inherited polymorphisms in the Human Leukocyte Antigen Region modify the association between varicella-zoster virus antibody reactivity and glioma prognosis
- 18 August 2023
- journal article
- letter
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 25 (10) , 1910-1912
Abstract
Varicella-zoster virus (VZV) is the ubiquitous alphaherpesvirus that causes chickenpox. After primary infection, VZV establishes latency in ganglia where it can reactivate many decades later causing significant morbidity (shingles or Herpes Zoster), and sometimes mortality. Evidence suggests VZV infected humans since the dawn of hominins resulting in long-term co-speciation where VZV evolved complex mechanisms to dodge both adaptive and innate immune responses.1 Decades of research have shown history of an antibody response to VZV infection is associated with lower adult glioma risk, the only virus that has been robustly associated with a reduced risk of any cancer.2,3 We recently extended the glioma-VZV inverse risk association for prognosis showing that a strong antibody response to VZV was associated with better survival (n = 1378 glioma patients).4 We performed a separate genome-wide association study of seroreactivity to 16 common viruses in 7895 UK Biobank participants which revealed an association with strength of VZV antibody response on chromosome 6 within the major histocompatibility complex.5 The lead variant in this region, rs9273325-G is inversely associated with VZV response (P = 8.2 × 10−28) and tags a wide ~3Mb block of linkage disequilibrium. While rs9273325 is likely not the functional variant, it tags a set of HLA polymorphisms that alter immune response to VZV, including the HLA-DRB1*0301 allele. The relevance of this locus for VZV response was further confirmed in transcriptome-wide analyses that detected significant associations for HLA-DQB1 and HLA-DQB2 expression in whole blood and brain tissues.Keywords
Funding Information
- National Institutes of Health (R01CA266676, T32CA151022, T32CA112355, R01CA52689, P50CA097257, R01CA126831, R01CA139020)
- National Brain Tumor Foundation
- UCSF-CTSI (UL1 RR024131)
This publication has 6 references indexed in Scilit:
- Antibodies to varicella-zoster virus and three other herpesviruses and survival in adults with gliomaNeuro-Oncology, 2023
- The immunogenetics of viral antigen response is associated with subtype-specific glioma risk and survivalThe American Journal of Human Genetics, 2022
- The landscape of host genetic factors involved in immune response to common viral infectionsGenome Medicine, 2020
- Immunobiology of Varicella-Zoster Virus InfectionThe Journal of Infectious Diseases, 2018
- History of chickenpox in glioma risk: a report from the glioma international case–control study (GICC)Cancer Medicine, 2016
- Does Prior Infection with Varicella-Zoster Virus Influence Risk of Adult Glioma?American Journal of Epidemiology, 1997